COSCIENS Biopharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $25.4M | $31.7M | $22.0M |
| FY2017 | $25.0M | $22.2M | $7.8M |
| FY2018 | $23.1M | $25.0M | $14.5M |
| FY2019 | $22.4M | $20.0M | $7.8M |
| FY2020 | $23.8M | $37.0M | $24.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $25.4M | $31.7M | $22.0M |
| FY2017 | $25.0M | $22.2M | $7.8M |
| FY2018 | $23.1M | $25.0M | $14.5M |
| FY2019 | $22.4M | $20.0M | $7.8M |
| FY2020 | $23.8M | $37.0M | $24.3M |